Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in CYTOKINETICS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 240,632 shares of CYTK (CYTOKINETICS INC), worth $15.9M as of 2026-Q1. The position was increased (+2.4% shares). CYTK represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$15.9M
Current Shares
240,632
Total Value Change
+$2.2M
Total Shares Change
-11,310
Other major holders of CYTK: BNP PARIBAS FINANCIAL MARKETS
Increased |
| 240,632 |
+2.4% |
| $15.9M |
| 0.0% |
| $60.72 |
29 |
| 2025-Q4 | Decreased | 235,049 | -1.4% | $14.9M | 0.0% | $61.37 | 0 |
| 2025-Q3 | Decreased | 238,382 | -42.7% | $13.1M | 0.0% | $53.89 | 0 |
| 2025-Q2 | Increased | 416,253 | +34.8% | $13.8M | 0.0% | $33.16 | 36 |
| 2025-Q1 | Decreased | 308,896 | -2.0% | $12.4M | 0.0% | $43.19 | 0 |
| 2024-Q4 | Increased | 315,250 | +18.2% | $14.8M | 0.0% | $47.15 | 33 |
| 2024-Q3 | Increased | 266,756 | +5.9% | $14.1M | 0.0% | $52.34 | 30 |
| 2024-Q2 | Increased | 251,942 | +113.7% | $13.7M | 0.0% | $54.18 | 45 |